1. Pittet D, Harbarth SJ. The intensive care unit.
Hospital Infections, 4th Edition, Ed: Bennett JV,
Brachman PS, Lippincott-Raven Publication,
Philadelphia, 1998, p.381-402.
2. Scahberg DR, Culver DH, Gaynes RP. Major
trends in the microbial etiology of nosocomial
infection. Am J Med 1991;91:185S-191S.
3. Kollef MH, Fraser VJ. Antibiotic resistance in
the intensive care unit. Ann Intern Med
2001;134:298-314.
4. Aygün G, Dikmen Y, Mete B, Utku T,
Murtezaoğlu A, Demirkıran O, Yılmaz M, Ürkmez
S, Şahin N, Öztürk R, Aktuğlu Y. Yoğun
bakım ünitesinde hastane infeksiyonu etkeni
olarak belirlenen Acinetobacter baumannii kö-
kenlerinin antibiyotik duyarlılığı. 16.Antibiyotik
ve Kemoterapi Kongresi, 4-9 Haziran 2001, Antalya,
Poster Özetleri Kitabı, Ankem Derg
2001;15:178.
5. Vincent JL, Bihari DJ, Suter PM. The prevalence
of nosocomial infection in intensive care
units in Europe: results of the European Prevalence
of Infection in Intensive Care (EPIC)
Study. JAMA 1995;274:639-644.
6. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou
ML, et al. Ventilator-associated pneumonia
caused by potentially drug-resistant bacteria.
Am J Respir Crit Care Med 1998;157:531-539.
7. Richards MJ, Edwards JR, Culver DH, Gaynes
RP. Nosocomial infections in medical intensive
care units in the United States. National Nosocomial
Infections Surveillance System. Crit Care
Med 1999;27:887-892.
8. Beck-Sague CM, Jarvis WR, the National Nosocomial
Infections Surveillance Sstem. Secular
trends in the epidemiology of nosocomial fungal
infections in the United States, 1980-90. J Infect
Dis 1993;167:1247-1251.
9. Rex JH, Wlash TJ, Sobel JD, Filler SC, Pappas
PG, Dismukes WE, Edwards JE. Practice guidelines
for the treatment of Candidiasis. Clin Infect
Dis 2000;30:662-278.
